{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:10:57Z","timestamp":1775848257915,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014392","name":"Avid Radiopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/s1474-4422(12)70142-4","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T21:17:10Z","timestamp":1340831830000},"page":"669-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":733,"title":["Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study"],"prefix":"10.1016","volume":"11","author":[{"given":"Christopher M","family":"Clark","sequence":"first","affiliation":[]},{"given":"Michael J","family":"Pontecorvo","sequence":"additional","affiliation":[]},{"given":"Thomas G","family":"Beach","sequence":"additional","affiliation":[]},{"given":"Barry J","family":"Bedell","sequence":"additional","affiliation":[]},{"given":"R Edward","family":"Coleman","sequence":"additional","affiliation":[]},{"given":"P Murali","family":"Doraiswamy","sequence":"additional","affiliation":[]},{"given":"Adam S","family":"Fleisher","sequence":"additional","affiliation":[]},{"given":"Eric M","family":"Reiman","sequence":"additional","affiliation":[]},{"given":"Marwan N","family":"Sabbagh","sequence":"additional","affiliation":[]},{"given":"Carl H","family":"Sadowsky","sequence":"additional","affiliation":[]},{"given":"Julie A","family":"Schneider","sequence":"additional","affiliation":[]},{"given":"Anupa","family":"Arora","sequence":"additional","affiliation":[]},{"given":"Alan P","family":"Carpenter","sequence":"additional","affiliation":[]},{"given":"Matthew L","family":"Flitter","sequence":"additional","affiliation":[]},{"given":"Abhinay D","family":"Joshi","sequence":"additional","affiliation":[]},{"given":"Michael J","family":"Krautkramer","sequence":"additional","affiliation":[]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Mark A","family":"Mintun","sequence":"additional","affiliation":[]},{"given":"Daniel M","family":"Skovronsky","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(12)70142-4_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid \u03b2 in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2967\/jnumed.108.060756","article-title":"Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging","volume":"50","author":"Koole","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/S1474-4422(12)70142-4_bib4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/S1474-4422(12)70142-4_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S1474-4422(12)70142-4_bib6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","article-title":"Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B","volume":"65","author":"Leinonen","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archneurol.2010.357","article-title":"In vivo fibrillar beta-amyloid detected using [11C] PiB positron emission tomography and neuropathologic assessment in older adults","volume":"68","author":"Sojkova","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib8","article-title":"Multimodality imaging characteristics of dementia with Lewy bodies","author":"Kantarci","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(12)70142-4_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.0b013e3181c7da8e","article-title":"In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia","volume":"74","author":"Burack","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(12)70142-4_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/archneurol.2011.153","article-title":"Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology","volume":"68","author":"Wolk","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2967\/jnumed.111.090340","article-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects","volume":"53","author":"Joshi","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/S1474-4422(12)70142-4_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1986.tb00677.x","article-title":"A comparative study of modified Bielschowsky. Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles","volume":"12","author":"Yamamoto","year":"1986","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(12)70142-4_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S1474-4422(12)70142-4_bib15","first-page":"S1","article-title":"The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease","volume":"18","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(12)70142-4_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","article-title":"Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions","volume":"64","author":"Bennett","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(12)70142-4_bib17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/jnnp.2004.054445","article-title":"Amyloid mediates the association of apolipoprotein E \u025b4 allele to cognitive function in older people","volume":"76","author":"Bennett","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(12)70142-4_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.22608","article-title":"Amyloid beta plaque growth in cognitively normal adults: longitudinal [11C] Pittsburgh Compound B data","volume":"70","author":"Vlassenko","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib19","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(12)70142-4_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(12)70142-4_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline: findings from the Alzheimer's Disease Neuroimaging Initiative","author":"Landau","year":"2012","journal-title":"Ann Neurol"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442212701424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442212701424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T10:15:05Z","timestamp":1761473705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442212701424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1474442212701424"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(12)70142-4","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(12)70142-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(12)70158-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}